. . Shares of Immumetp Ltd. . undefined, an Australian biotechnology listed on Nasdaq, rose 190% Thursday after the company posted positive results...
ByCAMEROON MAGAZINE - GM10/12/2020. . Small-cap immunotherapy company Immutep Ltd (ASX: IMM) is absolutely flying today. The Immutep share price is 57% higher. 14% at the...
ByCAMEROON MAGAZINE - GM10/12/2020. . U.S. stock futures fell Thursday as U.S. lawmakers appeared to be far from reaching consensus on the terms of the next...
ByCAMEROON MAGAZINE - GM10/12/2020. . Immutep's Chinese partner (IMM), EOC Pharma, will start a phase II clinical trial in patients with metastatic breast cancer.
ByCAMEROON MAGAZINE - GM10/12/2020. . Global biotechnology company Immutep (ASX: IMM) has announced that its Chinese partner EOC Pharma will start a phase II clinical trial...
ByCAMEROON MAGAZINE - GM10/12/2020. . Closing Bell is Stockhead's daily round-up of the ASX's biggest players - winners and losers alike. The data is collected after...
ByCAMEROON MAGAZINE - GM10/12/2020. . Immunotherapy company Immutep (ASX: IMM) announced what it describes as promising overall survival data from a breast cancer study with its...
ByCAMEROON MAGAZINE - GM10/12/2020Immutep Ltd (ASX: IMM) share price is up nearly 60% today following some encouraging results from the biopharmaceutical company's clinical trials
ByCAMEROON MAGAZINE - GM10/12/2020